International AIDS Conference Starts Sunday -- Aims to Turn the Tide on HIV Epidemic
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 20 July 2012 00:00
- Written by Liz Highleyman
The 19th International AIDS Conference (AIDS 2012) will kick of this Sunday, July 22, in Washington, DC. The meeting and its associated events are expected to bring together more than 25,000 researchers, clinicians and other service providers, policy-makers, activists, journalists, and people living with HIV to take stock of the epidemic at a juncture many are calling the "beginning of the end of AIDS." 
International AIDS Society Launches Global Scientific Strategy Towards an HIV Cure
- Details
- Category: Search for a Cure
- Published on Friday, 20 July 2012 00:00
- Written by press release
In the lead-up to the 19th International AIDS Conference next week in Washington, DC, the International AIDS Society has launched its first strategy for advocacy and research towards a cure for HIV, developed over the past 2 years by an international working group of experts in the field.
Transmission of Drug-resistant HIV Increases Risk of Treatment Failure
- Details
- Category: HIV Treatment
- Published on Friday, 20 August 2010 13:56
- Written by Liz Highleyman
People who become infected with HIV that already has at least 1 drug-resistance mutation are more likely to experience subsequent antiretroviral treatment failure, according to a presentation at the XVIII International AIDS Conference (AIDS 2010) last month in Vienna. Virological failure was more common among people taking NNRTI-based regimens, suggesting that protease inhibitors may be advisable if pre-treatment genotypic resistance testing is not available.
AIDS 2012 Conference Program Now Online, Global Village Events Free
- Details
- Category: AIDS 2012
- Published on Friday, 15 June 2012 00:00
- Written by Liz Highleyman
The full program for the XIX International AIDS Conference (AIDS 2012) was announced this week and is now available online at www.aids2012.org. Abstracts, slides, posters, and webcasts of selected presentations will also added to the website throughout the meeting.
AIDS 2010: CASCADE Study Shows Antiretroviral Therapy Is Beneficial above CD4 Cell Count of 350, Less Clear above 500
- Details
- Category: HIV Treatment
- Published on Tuesday, 27 July 2010 13:56
- Written by Liz Highleyman
Participants in the large CASCADE cohort who started antiretroviral therapy (ART) with a CD4 cell count in the 350-500 cells/mm3 range -- in accordance with current U.S. treatment guidelines -- had a reduced likelihood of death than those who deferred until later, investigators reported at the XVIII International AIDS Conference last week in Vienna. Starting above 500 cells/mm3, however, did not reduce the risk of progression to AIDS or death in this analysis.
Web Design and Development by